BACKGROUND: Although several interventions have shown reduced HIV incidence in clinical trials, the community-level effect of effective interventions on the epidemic when scaled up is unknown. We investigated whether a multicomponent, multilevel social and behavioural prevention strategy could reduce HIV incidence, increase HIV testing, reduce HIV risk behaviour, and change social and behavioural norms. METHODS: For this phase 3 cluster-randomised controlled trial, 34 communities in four sites in Africa and 14 communities in Thailand were randomly allocated in matched pairs to receive 36 months of community-based voluntary counselling and testing for HIV (intervention group) or standard counselling and testing alone (control group) between January, 2001, and December, 2011. The intervention was designed to make testing more accessible in communities, engage communities through outreach, and provide support services after testing. Randomisation was done by a computer-generated code and was not masked. Data were collected at baseline (n=14 567) and after intervention (n=56.683) by cross-sectional random surveys of community residents aged 18-32 years. The primary outcome was HIV incidence and was estimated with a cross-sectional multi-assay algorithm and antiretroviral drug screening assay. Thailand was excluded from incidence analyses because of low HIV prevalence. This trial is registered at ClinicalTrials.gov, number NCT00203749. FINDINGS: The estimated incidence of HIV in the intervention group was 1.52% versus 1.81% in the control group with an estimated reduction in HIV incidence of 13.9% (relative risk [RR] 0.86, 95% CI 0.73-1.02; p=0.082). HIV incidence was significantly reduced in women older than 24 years (RR=0.70, 0.54-0.90; p=0.0085), but not in other age or sex subgroups. Community-based voluntary counselling and testing increased testing rates by 25% overall (12-39; p=0.0003), by 45% (25-69; p<0·0001) in men and 15% (3-28; p=0.013) in women. No overall effect on sexual risk behaviour was recorded. Social norms regarding HIV testing were improved by 6% (95% CI 3-9) in communities in the intervention group. INTERPRETATION: These results are sufficiently robust, especially when taking into consideration the combined results of modest reductions in HIV incidence combined with increases in HIV testing and reductions in HIV risk behaviour, to recommend the Project Accept approach as an integral part of all interventions (including treatment as prevention) to reduce HIV transmission at the community level. FUNDING: US National Institute of Mental Health, the Division of AIDS of the US National Institute of Allergy and Infectious Diseases, and the Office of AIDS Research of the US National Institutes of Health.

Charles University Faculty of Mathematics and Physics Prague Czech Republic

Chiang Mai University Research Institute for Health Sciences Chiang Mai Thailand

Department of Pathology Baltimore MD USA

Fred Hutchinson Cancer Research Center Seattle WA USA

Human Sciences Research Council Dalbridge South Africa

Human Sciences Research Council Durban South Africa

Johns Hopkins Bloomberg School of Public Health Department of Epidemiology Baltimore MD USA

Johns Hopkins University School of Medicine Department of Medicine Baltimore MD USA; The National Institutes of Health Bethesda MD USA

Medical University of South Carolina Family Services Research Center Charleston SC USA

Muhimbili University of Health and Allied Sciences Muhimbili University Teaching Hospital Dar es Salaam Tanzania

University of California Los Angeles UCLA Center for World Health Los Angeles CA USA

University of California San Francisco Center for AIDS Prevention Studies San Francisco CA USA

University of Southampton Southampton General Hospital Southampton UK

University of the Witwatersrand Chris Hani Baragwanath Hospital Faculty of Health Sciences Perinatal HIV Research Unit Soweto South Africa

University of Zimbabwe College of Health Sciences Harare Zimbabwe

Komentář v

Lancet Glob Health. 2014 May;2(5):e242. doi: 10.1016/S2214-109X(14)70238-4. PubMed

Komentář v

Lancet Glob Health. 2014 Sep;2(9):e505. doi: 10.1016/S2214-109X(14)70265-7. PubMed

Zobrazit více v PubMed

Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11;365(6):493–505. PubMed PMC

Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010 Jun 12;375(9731):2092–2098. PubMed PMC

Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173–1180. PubMed

Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003 Sep 13;362(9387):859–868. PubMed

Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 2;367(5):399–410. PubMed PMC

Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587–2599. PubMed PMC

Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005 Nov;2(11):e298. PubMed PMC

Erratum in: PLoS Med. 2006 May;3(5):e298.

Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007 Feb 24;369(9562):643–656. PubMed

Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007 Feb 24;369(9562):657–666. PubMed

Holtgrave DR, Maulsby C, Wehrmeyer L, Hall HI. Behavioral Factors in Assessing Impact of HIV Treatment as Prevention. AIDS Behav. 2012;16(5):1085–1091. PubMed

Genberg BL, Kulich M, Kawichai S, et al. HIV risk behaviors in sub-Saharan Africa and Northern Thailand: baseline behavioral data from Project Accept. J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):309–319. PubMed PMC

Sweat M, Morin S, Celentano D, et al. Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis. 2011 Jul;11(7):525–532. PubMed PMC

Khumalo-Sakutukwa G, Morin SF, Fritz K, et al. Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand. J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):422–431. PubMed PMC

Laeyendecker O, Piwowar-Manning E, Fiamma A, et al. Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH Project Accept (HIV Prevention Trials Network 043) PLoS One. 2013 Jul 11;8(7):e68349. PubMed PMC

Project Accept (HPTN 043) [(accessed September 15, 2013)]; Web site: http://www.cbvct.med.ucla.edu/

Maman S, Lane T, Ntogwisangu J, et al. Using participatory mapping to inform a community-randomized trial of HIV counseling and testing. Field Methods. 2009 Nov;21:368–387. PubMed PMC

Chirowodza AC, Sikotoyi SV, Joseph P, et al. Using community ethnography and geographical information systems in a community based intervention trial in Vulindlela, South Africa (Project Accept-HPTN 043) J Community Psychol. 2009;37(1):41–57. PubMed PMC

Chingono A, Lane T, Chitumba A, Kulich M, Morin S. Balancing science and community concerns in resource-limited settings: Project Accept in rural Zimbabwe. Clin Trials. 2008;5(3):273–276. PubMed

Kevany S, Khumalo-Sakutukwa G, Murima O, et al. Health diplomacy and adapting global health interventions to local needs: findings from project accept (HPTN 043), a community-based intervention to reduce HIV incidence in populations at risk in Sub-Saharan Africa and Thailand. BMC Public Health. 2012 Jun 20;12:459. PubMed PMC

Tedrow VA, Zelaya CE, Kennedy CE, et al. No "magic bullet": exploring community mobilization strategies used in a multi-site community based randomized controlled trial: Project Accept (HPTN 043) AIDS Behav. 2012 Jul;16(5):1217–1226. PubMed PMC

Kawichai S, Celentano D, Srithanaviboonchai K, et al. NIMH Project Accept (HPTN 043) HIV/AIDS community mobilization (CM) to promote mobile HIV voluntary counseling and testing (MVCT) in rural communities in northern Thailand: Modifications by experience. AIDS Behav. 2012 Jul;16(5):1227–1237. PubMed PMC

Laeyendecker O, Kulich M, Donnell D, et al. Development of methods for cross-sectional incidence HIV estimation in a large community-randomized trial. PLoS One. 2013 Accepted for publication. PubMed PMC

Genberg BL, Hlavka Z, Konda KA, et al. A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med. 2009 Jun;68(12):2279–2287. PubMed PMC

Zelaya CE, Sivaram S, Johnson SC, et al. HIV/AIDS stigma: reliability and validity of a new measurement instrument in Chennai, India. AIDS Behav. 2008;12(5):781–788. PubMed

Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999;28(2):319–326. PubMed

UNAIDS Reference Group on Estimates, Modeling, and Projections: Statement on the use of the BED assay for estimation of HIV-1 incidence or epidemic monitoring. Weekly Epidemiol Rec. 2006;81:33–40. PubMed

Jurgensen M, Sandoy IF, Michelo C, Fylkesnes K, Group ZS. Effects of home-based voluntary counselling and testing on HIV-related stigma: findings from a cluster-randomized trial in Zambia. Soc Sci Med. 2013;81:18–25. PubMed

Rehle T, Shisana O, Pillay V, et al. National HIV incidence measures--new insights into the South African epidemic. S Afr Med J. 2007 Mar;97(3):194–199. PubMed

Zwakala Ndoda: a cluster and individually randomized trial aimed at improving testing, linkage, and adherence to treatment for hard-to reach men in KwaZulu-Natal, South Africa

Age-Related Differences in Socio-demographic and Behavioral Determinants of HIV Testing and Counseling in HPTN 043/NIMH Project Accept

Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043)

Determination of HIV Status in African Adults With Discordant HIV Rapid Tests

Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa

Effects of a community intervention on HIV prevention behaviors among men who experienced childhood sexual or physical abuse in four African settings: findings from NIMH Project Accept (HPTN 043)

Zobrazit více v PubMed

ClinicalTrials.gov
NCT00203749